Introducing Find Your Cure

Until now, CITADEL briefs lived in a dashboard built for researchers. Today we're opening the same engine to everyone with Find Your Cure.

What the agent does

Type a disease name. The Master Disease Agent then:

• searches PubMed, ClinicalTrials.gov, ChEMBL and UniProt at the same time, and checks our disease catalog for the name;
• asks an AI model to rank treatment candidates using only what those sources returned;
• runs our safety check, which flags withdrawn drugs and stopped trials and moves them down;
• attaches historical approval odds to every candidate.

You can watch each step finish, with how long every source took, and every candidate links to the records behind it.

About the odds

People asked us for a "probability of a cure". No honest dataset can give you that, so we don't show one. What we can show is how often drugs at a candidate's stage have historically gone on to be approved: about 8% from Phase 1, 15% from Phase 2 and 52% from Phase 3, based on BIO, Informa Pharma Intelligence and QLS Advisors' analysis of clinical development from 2011 to 2020.

That number tells you how far a drug still has to go. It doesn't tell you whether it will work for you. Rates also vary a lot between disease areas, and a flagged candidate's real odds are likely lower.

Who it's for

Researchers can size up a field in a minute. Patients, families and advocates can see which treatments are approved, which are in trials and which have failed, and bring sharper questions to their doctor. Find Your Cure is research information, not medical advice, and it never replaces a clinician.